Brief: Adagio Medical Submits Premarket Approval Application To FDA For Vclas® Ventricular Ablation System
21/05/2026 13:30
May 21 (Reuters) - Adagio Medical Holdings Inc ADGM.O: ADAGIO MEDICAL SUBMITS PREMARKET APPROVAL APPLICATION TO FDA FOR VCLAS® VENTRICULAR ABLATION SYSTEM FOR THE TREATMENT OF VENTRICULAR TACHYCARDIA Source text: ID:nBw4CS3dQa Further company coverage: ADGM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adagio Medical Holdings
See all newsBrief: Adagio Medical To Reduce Workforce By 25 Of 43 Employees Effective Sept 23, 2026 - SEC Filing
Brief: Adagio Medical Announces Strategic Review Process To Maximize Shareholder Value
Adagio Medical Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Adagio Medical Holdings Inc expected to post a loss of 28 cents a share - Earnings Preview
Brief: Adagio Medical Reports Second Quarter 2026 Results